Navigation Links
Vion Reports 2007 Third Quarter and Nine-Month Results
Date:11/7/2007

M), including additional personnel, drug production costs and other costs in support of a potential registration filing; (ii) stock-based compensation expense; and (iii) a gift to support research projects at a Yale University laboratory, partially offset by lower spending on preclinical drug production. In addition, marketing, general and administrative expenses were higher than the prior year period, primarily due to increased stock-based compensation expense, medical advisory board meetings and patent fees.

The Company reported $1.2 million and $3.4 million of stock-based compensation expense in the three-month and nine-month periods ended September 30, 2007, respectively, as compared to $413,000 and $1.4 million for the comparable 2006 periods.

The Company reported $3.7 million in interest expense for the nine months ended September 30, 2007 related to its private placement in February 2007 of convertible debt and warrants. There was no interest expense in 2006. Interest income increased from $1.6 million for the nine-month period ended September 30, 2006 to $2.6 million for the comparable 2007 period based on higher invested balances and higher interest rates in 2007.

The Company reported ending the quarter with $68.0 million in cash and cash equivalents. Based on its current operating plan, the Company reported that it had funds to operate the Company into the third quarter of 2009 excluding any expenses for commercialization of Cloretazine(R) (VNP40101M) in the United States. If the Company does commercialize Cloretazine(R) (VNP40101M) in the United States on its own, it would have to raise additional capital.

In August, the Company announced that it had completed the initial target accrual of 85 patients for its pivotal Phase II trial of Cloretazine(R) (VNP40101M) as a single agent in elderly de novo poor-risk acute myelogenous leukemia (AML). Recent FDA/ICH guidance recommends that an electrocardiograph evaluation (QT/QTc) study be i
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... By Dennis Thompson ... -- A newborn,s risk of developing celiac disease isn,t reduced ... found in wheat called gluten to an infant,s diet help ... a pair of new studies in the Oct. 2 ... put to rest hopes that a child could avoid celiac ...
(Date:10/2/2014)... The University of Nottingham could lead to the development ... drug resulting from the research, published in the journal ... to sufferers of chronic pain conditions such as traumatic ... available. , The work, led by Dr Lucy Donaldson ... with David Bates, Professor of Oncology in the University,s ...
(Date:10/1/2014)... the Journal of the American Medical Association ... moderate or severe chronic knee pain, acupuncture did not ... Melbourne randomly assigned 282 patients (50 years or older) ... or pretend laser treatment. , Treatments were delivered ... laser and sham (inactive) laser acupuncture. , Researcher Professor ...
(Date:10/1/2014)... a policy focus on expanding access to care ... continues to have significant dental disease. In this ... American Dental Association , researchers from Tufts University ... Dental Medicine report on the first large-scale survey ... by caregivers to adults with developmental disabilities. The ...
(Date:10/1/2014)... Insuranceragents.info has released a new blog post explaining how ... family members. , Life insurance plans provide important financial ... should always carry a life insurance policy as their ... the family. , Clients can choose from several ... coverage or from a permanent policy. No medical exam ...
Breaking Medicine News(10 mins):Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:Medical discovery first step on path to new painkillers 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2
... Doctor Confirms Fall Should Not Pose Setback and Expects the 89-Year-Old ... Evangelist ... Graham has,returned to his mountain home in Montreat, N.C. upon his ... stay.,He was admitted for observation after he tripped over one of ...
... 6 likely to develop some form of disease by ... 10 (HealthDay News) -- Liver transplant patients have a ... researchers in Finland. , In a new study ... , researchers investigated the cancer risk pattern in 540 ...
... RICHMOND, Va., Oct. 10 Do you think that ... town? Attend the October,17 open house at the Virginia ... how instructors there empower the blind and,visually impaired to ... center., The center, located at 401 Azalea Avenue, ...
... CITY, Utah, Oct. 10 NuView Life Sciences ... Life Sciences Inc.,(Trace), including operations of the linear ... Trace facility produces,Copper-64, Copper- 67, Indium-111, Iodine-123 and ... Crowe, NuView Chairman and,CEO, stated that "We are ...
... , , FRIDAY, Oct. 10 (HealthDay News) -- In a group ... with a higher death rate, according to a new study. ... Journal of General Internal Medicine , researchers from the ... 75.6 years) who had diabetes and were enrolled in a ...
... scientists have identified a protein that plays matchmaker between ... B cells, enabling them to interact in a way ... infection. Their finding may also explain why some ... from making this proteincalled SAPsuffer from lethal infections with ...
Cached Medicine News:Health News:Billy Graham Returns Home Following Hospital Observation 2Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3
(Date:10/1/2014)... DIEGO , Oct. 1, 2014 ... molecular diagnostics, announced today that Eli Diamond ... Kettering Cancer Center (MSK), presented clinical data from ... precision cancer monitoring platform for the determination of ... a liquid biopsy.  The results were presented to ...
(Date:10/1/2014)... Oct. 1, 2014   Royal Philips ... announced its eCareCoordinator and eCareCompanion telehealth applications have ... Drug Administration (FDA). A part of Philips Hospital ... eCareCoordinator and eCareCompanion are focused on patient care ... applications to be available through the cloud-based digital ...
(Date:10/1/2014)... Switzerland , October 1, 2014 ... Genomics and Next Generation Sequencing (NGS) data analysis, today ... run full cystic fibrosis analysis in a single NGS ... characterisation of all types of variants in a single ... Until now, it has not been possible to simultaneously ...
Breaking Medicine Technology:Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 2Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 3Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 4Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... heart organizations representing cardiologists and cardiothoracic surgeons released ... aortic valve replacement (TAVR) programs. The recommendations are ... aortic stenosis, a form of valvular heart disease, ... Since the Food and Drug ...
... Calif., March 1, 2012  Heritage Provider Network presented checks ... Heritage Health Prize competition at the Strata Conference in ... the 12 month mark. Once again, ... competition, winning the top spot.  Players include David Vogel, ...
Cached Medicine Technology:Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 2Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 3Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 4Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 5Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 2Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 3
Inquire...
Inquire...
Inquire...
Inquire...
Medicine Products: